mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.13 |
0.4 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.047 |
0.4 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.4 |
mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |